China SXT Pharmaceuticals (SXTC) Competitors $1.59 +0.02 (+1.27%) Closing price 04:00 PM EasternExtended Trading$1.58 -0.02 (-0.94%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SXTC vs. IMNM, VALN, UPB, PHAT, IMTX, ABUS, URGN, NAGE, TNGX, and PROKShould you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include Immunome (IMNM), Valneva (VALN), Upstream Bio (UPB), Phathom Pharmaceuticals (PHAT), Immatics (IMTX), Arbutus Biopharma (ABUS), Urogen Pharma (URGN), Niagen Bioscience (NAGE), Tango Therapeutics (TNGX), and ProKidney (PROK). These companies are all part of the "pharmaceutical products" industry. China SXT Pharmaceuticals vs. Its Competitors Immunome Valneva Upstream Bio Phathom Pharmaceuticals Immatics Arbutus Biopharma Urogen Pharma Niagen Bioscience Tango Therapeutics ProKidney China SXT Pharmaceuticals (NASDAQ:SXTC) and Immunome (NASDAQ:IMNM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends. Do analysts prefer SXTC or IMNM? Immunome has a consensus price target of $23.20, suggesting a potential upside of 128.57%. Given Immunome's stronger consensus rating and higher possible upside, analysts clearly believe Immunome is more favorable than China SXT Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China SXT Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Immunome 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, SXTC or IMNM? China SXT Pharmaceuticals has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Immunome has a beta of 1.92, indicating that its share price is 92% more volatile than the S&P 500. Which has better earnings and valuation, SXTC or IMNM? China SXT Pharmaceuticals has higher earnings, but lower revenue than Immunome. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina SXT Pharmaceuticals$1.74M106.03-$3.30MN/AN/AImmunome$9.04M97.73-$292.96M-$3.08-3.30 Is SXTC or IMNM more profitable? China SXT Pharmaceuticals has a net margin of 0.00% compared to Immunome's net margin of -1,687.08%. China SXT Pharmaceuticals' return on equity of 0.00% beat Immunome's return on equity.Company Net Margins Return on Equity Return on Assets China SXT PharmaceuticalsN/A N/A N/A Immunome -1,687.08%-76.10%-65.14% Do institutionals and insiders hold more shares of SXTC or IMNM? 5.0% of China SXT Pharmaceuticals shares are owned by institutional investors. Comparatively, 44.6% of Immunome shares are owned by institutional investors. 4.0% of China SXT Pharmaceuticals shares are owned by insiders. Comparatively, 7.7% of Immunome shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer SXTC or IMNM? In the previous week, Immunome had 13 more articles in the media than China SXT Pharmaceuticals. MarketBeat recorded 14 mentions for Immunome and 1 mentions for China SXT Pharmaceuticals. China SXT Pharmaceuticals' average media sentiment score of 1.89 beat Immunome's score of 0.69 indicating that China SXT Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment China SXT Pharmaceuticals Very Positive Immunome Positive SummaryImmunome beats China SXT Pharmaceuticals on 8 of the 14 factors compared between the two stocks. Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTC vs. The Competition Export to ExcelMetricChina SXT PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$182.16M$2.55B$5.75B$10.39BDividend YieldN/A54.21%5.75%4.64%P/E RatioN/A23.2675.7726.11Price / Sales106.03716.05544.74124.93Price / CashN/A176.2437.5461.24Price / Book0.075.1412.876.30Net Income-$3.30M$32.95M$3.29B$271.03M7 Day Performance-16.32%0.09%-0.26%-0.15%1 Month Performance7.43%5.04%3.84%6.41%1 Year Performance-67.04%1.02%68.35%28.81% China SXT Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTCChina SXT Pharmaceuticals1.2526 of 5 stars$1.59+1.3%N/A-69.6%$182.16M$1.74M0.0090Positive NewsGap UpIMNMImmunome2.1321 of 5 stars$10.51+7.5%$23.20+120.8%-23.3%$912.18M$9.04M-3.4040Analyst ForecastGap DownVALNValneva2.6185 of 5 stars$10.26+1.1%$15.00+46.2%+72.2%$881.64M$183.52M-10.47700Gap DownUPBUpstream Bio1.6188 of 5 stars$16.35-1.8%$56.50+245.7%N/A$879.00M$2.37M0.0038Positive NewsPHATPhathom Pharmaceuticals2.4949 of 5 stars$12.30+4.7%$17.50+42.3%-32.0%$872.21M$55.25M-2.60110IMTXImmatics2.8241 of 5 stars$7.08+3.4%$15.00+111.9%-37.2%$864.22M$168.65M-10.94260ABUSArbutus Biopharma2.1253 of 5 stars$4.46+0.6%$5.00+12.2%+11.7%$854.02M$6.17M-15.3690URGNUrogen Pharma4.1907 of 5 stars$17.91-0.5%$32.00+78.7%+37.7%$828.61M$90.40M-5.40200Positive NewsNAGENiagen Bioscience2.2083 of 5 stars$10.39+1.5%$13.42+29.2%N/A$828.60M$99.60M49.48120Positive NewsTNGXTango Therapeutics2.0907 of 5 stars$7.33-1.6%$10.50+43.2%+4.7%$816.76M$42.07M-5.5290Positive NewsGap DownPROKProKidney3.582 of 5 stars$2.78-1.2%$6.25+125.2%+19.3%$816.63M$80K-4.873Positive News Related Companies and Tools Related Companies Immunome Alternatives Valneva Alternatives Upstream Bio Alternatives Phathom Pharmaceuticals Alternatives Immatics Alternatives Arbutus Biopharma Alternatives Urogen Pharma Alternatives Niagen Bioscience Alternatives Tango Therapeutics Alternatives ProKidney Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTC) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SXTC Stock Alerts